Why Some Cancers May Not Respond to Immunotherapy – Drug Discovery & Development
Drug Discovery & Development |
Why Some Cancers May Not Respond to Immunotherapy
Drug Discovery & Development UCLA scientists have discovered that people with cancers containing genetic mutations JAK1 or JAK2, which are known to prevent tumors from recognizing or receiving signals from T cells to stop growing, will have little or no benefit from the … |
